Scott Rothbart
11 results.
November 28, 2018
High-throughput platform enables scientists to map activity of an emerging class of cancer drug targets
GRAND RAPIDS, Mich. (Nov. 28, 2018) — A powerful new biochemical platform is fueling the study of a family of enzymes that are promising targets for…
September 20, 2017
$2.375 million federal award to study epigenetic control systems, inform drug discovery
GRAND RAPIDS, MI (Sept. 20, 2017)—Van Andel Research Institute scientist Scott Rothbart, Ph.D., has been awarded a five-year, $2.375 million Maximizing…
November 3, 2016
New computational tool may speed drug discovery
GRAND RAPIDS, Mich. (November 3, 2016)—A new computational tool called fABMACS is helping scientists see beyond static images of proteins to more…